로딩 중…
지수 로딩 중…
Recursion Pharmaceuticals, Inc.
RXRX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$3.23+3.70%
2026-06-18
Price Chart
Recursion Pharmaceuticals, Inc.-36.89%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.71B |
| Revenue | $66M |
| Net Income | $-560M |
| Total Assets | $1.34B |
| Net Assets | $1.02B |
| Value | |
| P/B | 1.67x |
| P/S | 25.82x |
| FCF Yield | -19.04% |
| Profitability | |
| ROE | -54.62% |
| ROA | -41.79% |
| Op. Margin | -882.92% |
| Revenue Growth | -56.11% |
| Financial Health | |
| Debt Ratio | 30.71% |
| Total Debt | $72M |
| FCF | $-326M |
| Cash | $654M |
| Current Ratio | 5.47x |
| Performance | |
| 1Y Return | -36.89% |
| 1M Return | 13.16% |
| From 52W High | -55.08% |
| 1Y MDD | -58.17% |
| Trading | |
| Volume | 22,407,988 shares |
| Trading Value | $72M |
| Per Share | |
| EPS | $-1.22 |
| BPS | $2.15 |